Publications by authors named "L Yahia Cherif"

Objectives: Evaluate diabetic patients' knowledge, practices, and the prevalence of complications during Ramadan fasting (RF) before and after an education program.

Methods: We conducted a prospective study including 140 consecutive diabetic patients (DP) who intended to observe RF in 2023. Patients underwent a questionnaire and received pre-Ramadan education (PRE) according to the IDF-DAR 2021 recommendations.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the role of TERT, a subunit of telomerase, in high-grade cervical cancer, highlighting its activation linked to hypomethylation as a potential biomarker for disease progression.
  • Researchers analyzed 529 CpG sites in the TERT promoter region and related areas, discovering specific sites whose methylation patterns are significantly associated with genetic variants that increase cervical cancer risk.
  • Findings suggest that certain genetic variants are linked to lower levels of TERT and CLPTM1L mRNA, indicating a protective effect against cervical cancer, while HPV infection appears to increase levels of these genes.
View Article and Find Full Text PDF

Loss of function in epigenetic acting genes together with driver alterations in the PIK3CA pathway have been shown significantly associated with poor outcome in cervical squamous cell cancer. More recently, a CoxBoost analysis identified 16 gene alterations and 30 high level activated proteins to be of high interest, due to their association with either good or bad outcome, in the context of treatment received by chemoradiation. The objectives here were to review and confirm the significance of these molecular alterations as suggested by literature reports and to pinpoint alternate treatments options for poor-responders to chemoradiation.

View Article and Find Full Text PDF

Cancer progression is driven in part by genomic alterations. The genomic characterization of cancers has shown interpatient heterogeneity regarding driver alterations, leading to the concept that generation of genomic profiling in patients with cancer could allow the selection of effective therapies. Although DNA sequencing has been implemented in practice, it remains unclear how to use its results.

View Article and Find Full Text PDF